Biocompatible inks for 3D printing
View Patent ↗In one aspect, inks for use with a three-dimensional printing system are described herein. In some embodiments, an ink described herein comprises 10-60 wt. % oligomeric curable material; 30-80 wt. % monomeric curable material; and 10-35 wt. % self-curable light-sensitive oligomer, based on the total weight of the ink. Moreover, in some cases, the ink is free or substantially free of non-curable photoinitiator. For example, in some instances, the ink further comprises less than 0.1 wt. % or less than 0.05 wt. % non-curable photoinitiator, based on the total weight of the ink.
1. A method of printing a three-dimensional article comprising:
selectively depositing layers of an ink in a fluid state onto a substrate,
wherein the ink comprises
10-60 wt. % oligomeric curable material;
30-80 wt. % monomeric curable material; and
10-35 wt. % self-curable light-sensitive oligomer, based on the total weight of the ink,
wherein the ink comprises 0-0.01 wt. % non-curable photoinitiator, based on the total weight of the ink.
2. The method of claim 1 , wherein the layers of the ink are deposited according to an image of the three-dimensional article in a computer readable format.
3. The method of claim 1 further comprising curing the layers of the ink with UV light having an average wavelength of 340-370 nm.
4. A method of printing a three-dimensional article comprising:
retaining an ink in a fluid state in a container;
selectively applying energy to the ink in the container to solidify at least a portion of a first fluid layer of the ink, thereby forming a first solidified layer that defines a first cross-section of the article;
raising or lowering the first solidified layer to provide a second fluid layer of the ink at a surface of the fluid ink in the container; and
selectively applying energy to the ink in the container to solidify at least a portion of the second fluid layer of the ink, thereby forming a second solidified layer that defines a second cross-section of the article, the first cross-section and the second cross-section being bonded to one another in a z-direction,
wherein the ink comprises
10-60 wt. % oligomeric curable material;
30-80 wt. % monomeric curable material; and
10-35 wt. % self-curable light-sensitive oligomer, based on the total weight of the ink,
wherein the ink comprises 0-0.01 wt. % non-curable photoinitiator, based on the total weight of the ink.
5. The method of claim 1 , wherein the oligomeric curable material is present in the ink in an amount of 10-30 wt. %, based on the total weight of the ink.
6. The method of claim 1 , wherein the monomeric curable material is present in the ink in an amount of 40-70 wt. %, based on the total weight of the ink.
7. The method of claim 1 , wherein the self-curable light-sensitive oligomer is present in the ink in an amount of 20-35 wt. %, based on the total weight of the ink.
8. The method of claim 1 , wherein:
the oligomeric curable material is present in the ink in an amount of 10-30 wt. %;
the monomeric curable material is present in the ink in an amount of 40-70 wt. %; and
the self-curable light-sensitive oligomer is present in the ink in an amount of 20-35 wt. %, based on the total weight of the ink.
9. The method of claim 1 , wherein:
the oligomeric curable material comprises a urethane (meth)acrylate oligomer, a polyester (meth)acrylate oligomer, an epoxy (meth)acrylate oligomer, or a combination thereof; and
the monomeric curable material comprises a monofunctional (meth)acrylate, a difunctional (meth)acrylate, a trifunctional (meth)acrylate, a tetrafunctional (meth)acrylate, a pentafunctional (meth)acrylate, or a combination thereof.
10. The method of claim 1 , wherein the self-curable light-sensitive oligomer is a photoinitiator of the ink at 340-370 nm.
11. The method of claim 1 , wherein the self-curable light-sensitive oligomer comprises one or more ethyleneically unsaturated moieties.
12. The method of claim 1 , wherein the ink further comprises one or more additives selected from the group consisting of inhibitors and stabilizing agents.
13. The method of claim 1 , wherein the ink when cured has a cytotoxicity grade below 2 when measured according to ANSI/AAMI/ISO 10993-5:2009.